News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Patni Rajiv
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/26/2023 |
4
| Patni Rajiv (EVP, Chief R&D Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 45,000 shares
@ $0
Disposed/sold 90,000 options to buy
@ $99.12, valued at
$8.9M
|
|
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/10/2019 |
4
| Patni Rajiv (Chief Medical Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 30,000 shares
@ $0
Granted 60,000 options to buy
@ $6.81, valued at
$408.6k
|
|
| 03/21/2019 |
4
| Patni Rajiv (Chief Medical Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Sold 2,374 shares
@ $8, valued at
$19k
|
|
| 03/22/2018 |
4
| Patni Rajiv (Chief Medical Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Sold 1,252 shares
@ $25.94, valued at
$32.5k
|
|
| 03/09/2018 |
4
| Patni Rajiv (Chief Medical Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 9,125 shares
@ $0
Granted 54,750 options to buy
@ $25.66, valued at
$1.4M
|
|
| 03/22/2017 |
4
| Patni Rajiv (Chief Medical Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Sold 733 shares
@ $17.04, valued at
$12.5k
|
|
| 01/20/2017 |
4
| Patni Rajiv (Chief Medical Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 6,875 shares
@ $0
Granted 41,250 options to buy
@ $16.61, valued at
$685.2k
|
|
| 03/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|